Study guide
10.1 Myocardial Perfusion SPECT Imaging
ARRT Nuclear Medicine Technology Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Patient Assessment, Care & Emergency Procedures
1.1 Patient Assessment, Medical History & Communication 1.2 Venipuncture, Vascular Access & Emergency Response
2 Chapter 2: Ethical, Legal & Professional Standards
2.1 ARRT Code of Ethics & Patient Rights 2.2 Patient Care in Special Populations & Infection Control
3 Chapter 3: Radiation Physics & Biological Effects
3.1 Atomic Structure, Nuclear Decay & Radiation Interactions 3.2 Biological Effects of Radiation & Radiobiology Principles
4 Chapter 4: Radiation Protection, ALARA & NRC Regulations
4.1 Radiation Protection Principles & ALARA Implementation 4.2 NRC Regulations, Occupational Dose Limits & Area Monitoring 4.3 Radioactive Spills, Contamination Control & Medical Events
5 Chapter 5: Gamma Camera Instrumentation & Physics
5.1 Gamma Camera Components & Signal Processing 5.2 Collimation Principles & Types 5.3 Quality Control of Gamma Cameras
6 Chapter 6: Advanced Imaging Modalities: SPECT, PET/CT & QC
6.1 SPECT Instrumentation, Reconstruction & Quality Control 6.2 PET/CT Instrumentation, Coincidence Detection & Crystals 6.3 PET/CT Quality Control, Attenuation Correction & PACS
7 Chapter 7: Radionuclide Production & Generator Systems
7.1 Radionuclide Production Methods 7.2 Mo-99/Tc-99m Generator Operations & Elution 7.3 Generator Quality Control & Breakthrough Testing
8 Chapter 8: Radiopharmaceutical Preparation, QC & Administration
8.1 Radiopharmaceutical Preparation & Chemistry 8.2 Radiochemical Purity & Dose Calibrator Quality Control 8.3 Dose Calculations, Unit Dose Dispensing & Waste Management
9 Chapter 9: Endocrine, Central Nervous System & Gastrointestinal Imaging
9.1 Thyroid & Parathyroid Imaging & Uptake 9.2 Central Nervous System Imaging 9.3 Gastrointestinal & Hepatobiliary Imaging
10 Chapter 10: Cardiovascular Imaging Procedures
10.1 Myocardial Perfusion SPECT Imaging 10.2 Cardiac Stress Protocols & Vascular Anatomy 10.3 Ventricular Function & MUGA Scans 10.4 Myocardial Viability Imaging 10.5 Cardiac Amyloid Imaging (Tc-99m PYP)
11 Chapter 11: Pulmonary, Skeletal & Renal Imaging Procedures
11.1 Pulmonary Ventilation & Perfusion (V/Q) Imaging 11.2 Skeletal System Imaging & 3-Phase Bone Scans 11.3 Renal & Genitourinary Imaging
12 Chapter 12: Tumor, Infection, Hematology & Radiopharmaceutical Therapy
12.1 Oncology PET/CT Imaging with F-18 FDG 12.2 Infection & Tumor Imaging with Special Radiopharmaceuticals 12.3 Therapeutic Radiopharmaceuticals & Radiation Safety Precautions 12.4 Lymphoscintigraphy & Sentinel Lymph Node Mapping
10.1 Myocardial Perfusion SPECT Imaging
Key Takeaways Explain This Topic AI
Tc-99m sestamibi and Tc-99m tetrofosmin are lipophilic agents with uptake proportional to regional myocardial blood flow, remaining fixed without significant redistribution.
Tl-201 thallous chloride enters myocardial cells via the Na+/K+ ATPase pump, behaving as a potassium analog, and undergoes redistribution over time.
1-day and 2-day stress/rest protocols differ in dosing and timing to optimize image quality and limit patient radiation exposure.
Attenuation artifacts are a primary source of false-positive studies, typically caused by breast tissue (anterior wall) and diaphragmatic attenuation (inferior wall).
Last updated: July 2026
10.1 Myocardial Perfusion SPECT Imaging
Quick Answer: Myocardial Perfusion Imaging (MPI) using Single-Photon Emission Computed Tomography (SPECT) evaluates regional myocardial blood flow at stress and rest to detect coronary artery disease (CAD). Technetium-99m agents (sestamibi, tetrofosmin) exhibit fixed uptake via mitochondrial trapping, whereas Thallium-201 undergoes continuous Na+/K+ pump-driven redistribution. Protocol design (1-day rest-stress vs 2-day vs dual-isotope) and soft-tissue attenuation correction (breast/diaphragm) are essential for diagnostic accuracy.
Myocardial Perfusion SPECT is one of the most widely performed diagnostic procedures in nuclear medicine. By assessing regional relative blood flow to the left ventricular myocardium under peak physiological or pharmacologic stress compared to resting conditions, SPECT MPI accurately identifies reversible ischemia (indicative of hemodynamically significant coronary stenoses) versus fixed defects (indicative of prior myocardial infarction or scar).
Radiopharmaceutical Pharmacokinetics & Uptake Mechanisms
Selecting the proper radiopharmaceutical requires understanding its cellular transport, extraction fraction, clearance pathways, and physical decay characteristics.
1. Tc-99m Sestamibi (Cardiolite) & Tc-99m Tetrofosmin (Myoview)
Both sestamibi and tetrofosmin are lipophilic cationic complexes that cross the cell membrane and localize inside cardiac myocytes.
Uptake Mechanism: Driven by negative electrical potential gradients across the sarcolemmal plasma membrane ( − 130 mV -130\ \text{mV} − 130 mV ) and the inner mitochondrial membrane ( − 160 mV -160\ \text{mV} − 160 mV ). Once inside the cytoplasm, > 90 % >90\% > 90% of the agent becomes trapped in the mitochondrial matrix.
First-Pass Extraction Fraction: Approximately 60 % 60\% 60% for sestamibi and 50 % 50\% 50% for tetrofosmin at normal physiological blood flow rates. At high flow rates during maximal exercise or vasodilator stress, extraction experiences a "roll-off" phenomenon (hyperemic plateau).
Redistribution Dynamics: Minimal to no redistribution ( < 5 % <5\% < 5% over 4 hours). Radiotracer distribution reflects regional blood flow at the exact moment of intravenous injection , regardless of when imaging commences (up to 3-4 hours post-injection). This allows stress testing in a cardiac lab followed by delayed SPECT camera acquisition.
Clearance & Excretion: Hepatobiliary and renal clearance. Subdiaphragmatic activity in the liver, gallbladder, and bowel loop can overlap the inferior left ventricular wall. Tetrofosmin clears faster from hepatic tissue than sestamibi, enabling earlier post-stress acquisition ( 20 − 30 min 20-30\ \text{min} 20 − 30 min vs 45 − 60 min 45-60\ \text{min} 45 − 60 min for sestamibi).
2. Thallium-201 (Tl-201) Thallous Chloride
Thallium-201 is a monovalent heavy-metal cation that acts as a physiological analog of potassium ( K + \text{K}^+ K + ).
Uptake Mechanism: Actively transported into myocytes via the sarcolemmal Na + / K + \text{Na}^+/\text{K}^+ Na + / K + ATPase pump ( 85 % 85\% 85% first-pass extraction fraction).
Redistribution Phenomenon: Unlike Tc-99m agents, Tl-201 undergoes continuous dynamic exchange between intracellular myocardium and systemic blood pool. Over 3 − 24 3-24 3 − 24 hours, Tl-201 washes out of normal myocardium faster than ischemic myocardium, gradually equilibrating across all viable myocardium.
Clinical Interpretation: An initial stress defect that normalizes on 3-4 hour delayed images represents reversible ischemia . A defect that remains fixed at 4 hours but normalizes on 24-hour delayed images or post-reinjection images represents viable/hibernating myocardium . A defect that remains fixed across all timepoints represents non-viable scar (infarct) .
Physical Characteristics: Decays by electron capture ( T 1 / 2 = 73.1 hours T_{1/2} = 73.1\ \text{hours} T 1/2 = 73.1 hours ), emitting characteristic mercury X-rays ( 69 − 83 keV 69-83\ \text{keV} 69 − 83 keV ) and principal gamma photons ( 135 , 167 keV 135, 167\ \text{keV} 135 , 167 keV ). The low energy of mercury X-rays makes Tl-201 highly susceptible to soft-tissue attenuation.
Parameter Tc-99m Sestamibi Tc-99m Tetrofosmin Tl-201 Thallous Chloride
Uptake Mechanism Passive diffusion, Mitochondrial trapping Passive diffusion, Mitochondrial trapping Active Na + / K + \text{Na}^+/\text{K}^+ Na + / K + ATPase pump
- Extraction Fraction ∼ 60 % \sim 60\% ∼ 60% ∼ 50 % \sim 50\% ∼ 50% ∼ 85 % \sim 85\% ∼ 85%
- Redistribution None (Fixed) None (Fixed) Extensive ( 3 − 24 hours 3-24\ \text{hours} 3 − 24 hours )
Photon Energy 140 keV 140\ \text{keV} 140 keV gamma 140 keV 140\ \text{keV} 140 keV gamma 69 − 83 keV 69-83\ \text{keV} 69 − 83 keV Hg X-rays
Physical Half-Life 6.02 hours 6.02\ \text{hours} 6.02 hours 6.02 hours 6.02\ \text{hours} 6.02 hours 73.1 hours 73.1\ \text{hours} 73.1 hours
- SPECT Acquisition Protocols
- 1. One-Day Rest-Stress / Stress-Rest Tc-99m Protocol
Convenient for outpatients, completed within 4-5 hours.
First Phase (Rest or Stress): Low dose ( 8 − 12 mCi 8-12\ \text{mCi} 8 − 12 mCi of Tc-99m agent) injected. SPECT acquisition performed 45 − 60 minutes 45-60\ \text{minutes} 45 − 60 minutes later.
Second Phase (Stress or Rest): High dose ( 24 − 36 mCi 24-36\ \text{mCi} 24 − 36 mCi ) administered 3 − 4 hours 3-4\ \text{hours} 3 − 4 hours after the first dose. The 3 : 1 3:1 3 : 1 dose ratio ensures that photon statistics from the second administration overwhelm residual background activity from the first dose.
2. Two-Day Tc-99m Protocol
Preferred for patients with severe obesity ( BMI > 35 kg/m 2 \text{BMI} > 35\ \text{kg/m}^2 BMI > 35 kg/m 2 ).
Both rest and stress studies utilize high doses ( 25 − 30 mCi 25-30\ \text{mCi} 25 − 30 mCi ), separated by 24 hours. Eliminates crosstalk from residual background activity and provides superior count statistics through thick body wall tissue.
3. Dual-Isotope Rapid Protocol
Rest study performed with Tl-201 \text{Tl-201} Tl-201 ( 3 − 3.5 mCi 3-3.5\ \text{mCi} 3 − 3.5 mCi ), imaged immediately. Stress study performed with Tc-99m \text{Tc-99m} Tc-99m agent ( 25 − 30 mCi 25-30\ \text{mCi} 25 − 30 mCi ) 1 hour 1\ \text{hour} 1 hour later. Total imaging time < 2 hours <2\ \text{hours} < 2 hours , but increases patient radiation exposure.
Soft Tissue Attenuation Artifacts & Resolution Strategies
Attenuating structures absorb emitted gamma rays, causing false-positive apparent perfusion defects:
Breast Attenuation: Dense breast tissue or large breast implants attenuate photons from the anterior, anterolateral, or apical walls in female patients.
Diaphragmatic / Subdiaphragmatic Attenuation: Left hemidiaphragm, subdiaphragmatic fat, or elevated abdominal organs attenuate counts from the inferior wall in male and obese patients.
Review of Raw Cine Projections: Technologists must display the 360-degree raw projection data in cinematic mode to spot breast shadow movement, diaphragmatic creeping, or patient motion.
CT Attenuation Correction (CTAC): Hybrid SPECT/CT systems acquire a low-dose CT scan to generate a patient-specific electron density map ( μ \mu μ -map), converting CT Hounsfield units to 140 keV 140\ \text{keV} 140 keV attenuation coefficients. Misregistration between SPECT and CT maps (due to breathing mismatches) can create artificial defect artifacts.
ECG-Gated SPECT Functional Validation: Gating divides the cardiac cycle into 8 or 16 frames. True transmural myocardial infarction demonstrates both a perfusion defect AND regional wall motion abnormality (akinesis/dyskinesis) with absent wall thickening. In contrast, soft-tissue attenuation artifacts display normal regional wall motion and normal end-systolic wall thickening ( > 20 % >20\% > 20% brightening).